Duta Wacana Christian University Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2020
NCT04425590
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Duta Wacana Christian University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 3)

Diabetic Neuropathies (Phase 3)

Ischemia (Phase 3)

Pain (Phase 3)

Peripheral Nervous System Diseases (Phase 3)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6